Simvastatin After Aneurysmal Subarachnoid Hemorrhage
Completed
Phase N/A ResultsSummary of Purpose
To determine whether simvastatin reduces serum markers of brain injury and lessens vasospasm after SAH.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 4 August 2005.
Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
Sponsors
- NIH research grant R21NS4487-01 & Merck and Co, Inc. D.T.L
Trial Design
Randomized, double-blind, placebo-controlled trial.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 39
- Number of Centers: 1
- Max Time from Onset: 48 Hours
Principal Investigator
-
John R. Lynch, M.D.
John R. Lynch, M.D. Box 2900 Duke University Medical Center, Durham, NC 27710